Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
Patent 5935597 Issued on August 10, 1999. Estimated Expiration Date: 
June 13, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
June 13, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesTransdermal drug delivery device Sulfonic acid derivatives in the treatment of viral diseases Percutaneous drug delivery system Patent #: 5534260 InventorAssigneeApplicationNo. 874425 filed on 06/13/1997US Classes:424/449, Transdermal or percutaneous424/422, Implant or insert424/448Pressure sensitive adhesive meansExaminersPrimary: Brouillette, GabrielleAttorney, Agent or FirmInternational ClassA61F 013/00Foreign Application Priority Data1995-12-15 ZAAbstractNovel drug delivery devices, methods and therapeutic compositions are described for treating viral and microbial infections and wasting syndromes in an animal, including a human patient. According to the invention, a polar compound such as dimethylformamide or dimethylsulfoxide is administered to a patient in need of treatment, preferably by a transdermal route. The invention further provides a vaccine prepared from antibodies harvested from the body of a patient treated by the method of the invention for a viral infection. | |
